Skip to content
ADVERTISEMENT

Women’s health should be a business priority, not just a personal one

Dr Helen O'Neill, CEO of Hertility, makes the case for greater employer support for women’s reproductive and hormonal health.

Dr Helen O'Neill
ADVERTISEMENT

We asked working women a simple question. Had a healthcare professional ever failed to take their reproductive or hormonal symptoms seriously? 93% said yes, a number that matters to HR leaders because it’s already sitting inside your absence, attrition and productivity figures.

We have built one of the largest multimodal women’s health datasets in the world, because the research, or lack of it, showed us the female body has been under-studied, under-funded and dismissed, and that nobody inside the system was going to fix it. McKinsey’s analysis highlights women make up 57% of the NHS waiting list and gynaecology alone accounts for around one in eight of all adult waits. 

Businesses aren’t the reason the gender health gap exists. But their own health benefits often mirror it. Private Medical Insurance (PMI) labels ongoing conditions as ‘chronic’ and anything non-urgent as ‘elective,’ often excluding cover. PMOS, endometriosis, adenomyosis and perimenopause often fall into those categories.

Women’s health also remains taboo at work, forcing employees to manage conditions alone. Three-quarters of women in our recent poll have never disclosed a reproductive health event at work, two-thirds citing fear of how it would be received, so HR works from absence and attrition figures that understate the real cost.

McKinsey cites the UK diagnosis time for endometriosis at nine years and four months. That’s nine years without answers, scattered sick days and holiday days used around flare-ups. Adenomyosis and PMOS follow the same pattern, often affecting someone for their entire working years. 

ADVERTISEMENT

In our Hertility Workplace Health Report, female employees logged an average of five work-impacting symptoms including fatigue, pain, brain fog and anxiety, and in our recent poll 93% said symptoms affect their performance, concentration or energy at work. 

Our poll highlighted 90% of female employees felt their hormonal health has impacted their mental health, confidence or career progression. 

Budget is the barrier businesses raise most often for implementing health support, but the perspective needs to change. Invest in healthcare, or keep absorbing the cost of absence, attrition and lost productivity. 

ADVERTISEMENT

Using Hertility’s cost calculator, a 1,000-employee company with a 50% female workforce could be losing upwards of £1.5 million annually from conditions exclusively affecting women.

Against McKinsey’s £36bn UK economic opportunity estimate, we agree this number is extremely conservative, but the burden of conditions like menopause, endometriosis and PMOS, which predominantly affect working-age women, is still hidden by delayed diagnosis and incomplete data. 

ADVERTISEMENT

Replacing an experienced employee costs an average of £30,614 in the UK, rising up to 213% of salary for senior roles, often held by women in their perimenopausal or menopausal years. Symptoms associated with this transition are often not supported, get misread as declining capability and result in experienced women leaving. 

ADVERTISEMENT

Hertility data shows women suspect perimenopause at an average age of 39, yet textbooks and clinics wait until the late forties or early fifties to acknowledge it. Access to proactive care could help prevent this.

McKinsey notes the UK is the only G7 economy whose workforce remains smaller than before the pandemic, with long-term sickness leaving 2.78 million people economically inactive.  Replacing people is getting harder, and losing people is a cost that compounds. 

The cause is the conditions going unnoticed, undiagnosed and unsupported for too long. Preventative screening and early detection help close that gap. 

In practice, HR can support their female workforce by: 

ADVERTISEMENT
  • Offering proactive/preventative health screening and clinical services as part of your benefits package 
  • Plugging gaps in current benefits offerings, e.g. tailored support for reproductive and hormonal health 
  • Upskilling managers, helping them manage difficult conversations with empathy, recognise symptoms and signpost support 
  • Introducing policies covering a woman’s whole reproductive life-span, not just menopause and fertility, but extending to PMOS, endometriosis and menstrual health 

Closing the gap would mean fewer working days lost to treatable symptoms, better output from people no longer operating at half capacity, and retaining more experienced colleagues.

Dr Helen O’Neill is CEO of Hertility and associate professor at UCL